Post-Translational Modifications (PTMs): Many therapeutic peptides undergo PTMs (e.g., amidation, glycosylation) that impact their biological activity
Chemical & Handling Information Type: Synthetic FOXO4-interacting peptide analog Peptide length: Short peptide (exact sequence per specification/lot) Appearance: White to off-white lyophilized powder Specifications Peptide: FOXO4-DRI Amount: 5 mg per vial Form: Lyophilized powder Purity: 99% (HPLC)
MIN6B1 were treated as INS-1 832/3 but in Krebs-HEPES-bicarbonate (KHB) buffer (140 mM NaCl, 3.6 mM KCl, 1.5 mM CaCl 2 , 0.5 mM MgSO 4 , 0.5 mM NaH 2 PO 4 , 2 mM NaHCO 3 , 10 mM HEPES, and 1% BSA
A viral titre assay revealed that after the GPX4 protein was knocked down, the inhibitory effect of TNF- on EBV reactivation was significantly impaired (Fig
For a substance or method to be included on the WADA Prohibited List, the substance or method must meet any two of the following three criteria: 1) It has the potential to enhance or enhances sport performance 2) It represents and actual or potential health risk to the athlete 3) It violates the spirit of sport Harmful Effects Although the effects of IGF-1 are well examined, the distribution and utilization for its proper medical use in humans in the pharmaceutical market is extremely limited
